South and Central America Cartilage degeneration Market Analysis and Opportunities by 2027

The South & Central America cartilage degeneration market is expected to reach US$ 1,195.57 million by 2027 from US$ 959.32 million in 2019; it is estimated to grow at a CAGR of 2.9% from 2020 to 2027.

Increasing prevalence of sports injuries and obesity in the region are the key factors driving the growth of cartilage degeneration. However high cost of cartilage therapies is the major factor hindering the market growth in South & Central America.

Cartilage plays an important role in smooth mechanical movements of bones and muscles. Degeneration of cartilage can lead to pain and chronic inflammation in joints. Furthermore, this damaged cartilage can potentially influence quality of the life. Continual research and development is leading to innovation of new techniques and methodologies to deal with damages cartilages. Some of these techniques comprises joint replacement, cell therapies, and chondroplasty amongst others.

Athletes and players frequently suffer due to injuries during sports activities. These injuries have significant potential to damage cartilage and ligaments. An increasing number of sports injuries among players and athletes is anticipated to drive the growth of the cartilage degeneration market during the forecast period. For instance. Traumatic injuries (80%) were more common than overuse injuries (20%) in football matches. The highest distribution of injury was in the lower limbs (80%), followed by the head (8.6%), spine (5.7%) and upper limbs (5.7%). The body regions most affected were the knee (28.6%), feet (17.1%), ankle (11.4%) and thigh (11.4%). The increasing number of participations in sports leads to the surge in sports injuries among the participants, which will eventually drive the growth of the cartilage degeneration market by 2027. For instance, football is the most popular sport in Brazil. The Brazil national football team, governed by the Confederação Brasileira de Futebol, has won the FIFA World Cup a record 5 times. Thus, the sports participation has been rapidly increasing boosting the market growth in the forecasted period.

The COVID-19 pandemic has become the most significant challenge in this region. The south America has reported 3,951,893 cases as of 28 July 2020. The number of growing COVID-19 cases has been reported, such as, Brazil (2,555,518). Many countries in the region have less developed and underfunded health systems, such as Peru, has less than 1000 intensive care unit beds for its 32 million inhabitants. A lack of ICU beds and ventilators is common across the region. Apart from this, a huge population already face a growing burden of non-communicable diseases; making them more vulnerable to the virus. Moreover, economic uncertainties and ongoing conflicts are worsening the condition in the region.

Rest of South & Central America Cartilage Degeneration Market, Revenue and Forecast to 2027 (US$ Mn)

SOUTH & CENTRAL AMERICA CARTILAGE DEGENERATION MARKET SEGMENTATION

By Procedure Type

• Joint Replacement
• Chondroplasty
• Cell-based Cartilage Resurfacing
• Osteochondral Transplant
• Meniscus Transplants
• Others

By Application

• Knee
• Hips
• Other

By End User

• Hospitals and Specialty Clinics
• Ambulatory Surgical Centers
• Academic and Research Institutes

By Country

• Brazil
• Argentina
• Rest of South & Central America

Company Profiles

• B. Braun Melsungen AG
• Smith & Nephew
• Stryker Corporation
• CartiHeal, Inc
• Vericel Corporation

South and Central America Cartilage degeneration Report Scope